Form D · Biotechnology

CONJUGON INC

Madison, WI · CIK 0001209987

Offering snapshot reported Apr 25, 2016 · SEC filing

Reported sold
$375K
Offering amount: $5.75M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 8, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 25, 2016Initial$375,000No comparison1SEC filing
Feb 9, 2015Initial$700,000No comparison4SEC filing
Dec 4, 2013Initial$595,000No comparison14SEC filing
May 10, 2010Initial$1,925,000No comparison3SEC filing
Jan 3, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-261936

Source: Form D, filed Apr 25, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Burgess Director
Anthony Clemento Director
Paul T. Evans Director
Gary Greenwood Director, Executive
Robert Lippert Director, Executive
Alicia Loffler Director
Brian Mc Loughlin Director
Gary Noskin Director
Carl Spalding Director
H. Thomas Watkins Director
H. Thomas Watkins Director
Steven R. Watt Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
505 South Rosa Road Suite 29
Madison, WI, 53719